Program News
News and stories about members of the UNC Lineberger Clinical Research Program
-
Adaptive whole-genome sequencing could transform childhood leukemia diagnosis
UNC Lineberger researchers have demonstrated a faster, more cost-effective approach to analyzing the genetic makeup of pediatric acute leukemia. Determining a cancer’s genomic classification is critical to developing a more effective treatment plan tailored to a patient’s tumor.
-
Gastrointestinal oncologist discusses increase in younger patients with colorectal cancer
The rise of colorectal cancer cases in people under 45 has steadily increased, prompting concern among oncologists and researchers. Ashwin Somasundaram, MD, talks about colorectal cancer and this concerning trend.
-
Improved multiple myeloma therapies help patients live longer, better lives
March is Multiple Myeloma Awareness Month, an opportunity to shed light on a disease that accounts for approximately 10% of all blood cancers. Treatment options for multiple myeloma have expanded in recent years, leading to better patient outcomes and longer survival rates.
-
Immunotherapy and targeted therapy combination proves effective against metastatic colorectal cancer
UNC Lineberger researchers have demonstrated that combining two immunotherapy drugs with a targeted therapy drug proved effective in treating the most common form of metastatic colorectal cancer.
-
Study now recruiting patients to treat PANcreatic adenocarcinoma with Gemcitabine, Erlotinib, and nAb-paclitaxel (PANGEA)
UNC Lineberger has opened a two-arm clinical trial to determine the optimal combination treatment for patients with advanced unresectable or metastatic basal-like subtype pancreatic ductal adenocarcinoma.
-
Malawi cancer program develops diagnostic breakthrough
Part of UNC Project Malawi, the cancer program provides clinical care, pathology training and other services to the African nation. The program is entering the second phase of developing a low-cost cancer diagnosis method.
-
UNC Lineberger hosts NCI in gastrointestinal cancer SPORE Investigators Meeting
The nation’s top gastrointestinal cancer clinical translational researchers convened in Chapel Hill for the 2025 GI SPORE Investigators Meeting.
-
International breast cancer meeting features UNC Lineberger research
More than 10,000 cancer researchers, clinicians and patient advocates from across the globe are expected to attend this year’s San Antonio Breast Cancer Symposium. The meeting will feature presentations by several UNC faculty members and trainees.
-
UNC researchers presenting research advances at American Society of Hematology annual meeting
Nearly two dozen UNC faculty members and trainees will present research and participate in scientific symposia and educational sessions at the ASH Annual Meeting.
-
UNC Lineberger shines at Carolina Hurricanes’ Hockey Fights Cancer game
H.J. Kim, MD, was honored as the Hero of the Game and Robert Ferris, MD, PhD, sounded the hurricane warning siren.
-
Treatment advances, predictive biomarkers stand to improve bladder cancer care
In an editorial, Matthew Milowsky, MD, FASCO, wrote that the promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients.
-
UNC Lineberger joins national initiative to advance cervical cancer screening through HPV self-testing
UNC Lineberger is the first cancer center to enroll participants in a national study focused on expanding access to cervical cancer screening through self-testing, an approach that could help reduce the number of women diagnosed with cervical cancer due to underscreening.
-
Serody and Yeh honored with Battle Distinguished Cancer Research Award
Jonathan Serody, MD, and Jen Jen Yeh, MD, were named the 2023 recipients of the Hyman L. Battle Distinguished Cancer Research Award, recognizing their significant scientific achievements.
-
New treatments offer promise to people with acute myeloid leukemia
Joshua Zeidner, MD, a hematologist/oncologist specializing in the management of acute leukemia, explains some of the advances in the treatment of acute myeloid leukemia (AML).
-
Rashid awarded grant to develop AI tool that recommends optimal clinical trials to pancreatic cancer patients
Naim Rashid, PhD, has received a Department of Defense Pancreatic Cancer Research Program pilot award to build an AI tool that generates personalized clinical trial recommendations for patients with PDAC.